Literature DB >> 26217703

Genome-wide transcriptional profiling data from chronic cutaneous lupus erythematosus (CCLE) peripheral blood.

R Dey-Rao1, A A Sinha1.   

Abstract

The disease Lupus erythematosus (LE), exhibits a variety of clinical manifestations with potentially wide-ranging multi-organ damage to joints, tendons, kidney, lung, heart, blood vessels, central nervous system and skin [1,2] Systemic changes are likely to trigger organ specific manifestation of the disease. Here, we provide the data examined to address the gap in knowledge regarding causes and mechanisms contributing to the autoimmune attack on skin in chronic cutaneous lupus erythematosus (CCLE). The raw gene expression data files (CEL files) are provided with this article [3].

Entities:  

Keywords:  B, Blood; LE, CCLE Chronic cutaneous lupus erythematosus; NL, Normal control

Year:  2014        PMID: 26217703      PMCID: PMC4459765          DOI: 10.1016/j.dib.2014.11.006

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications table

Value of the data

The raw genome-wide transcriptional profiling data from CCLE and healthy patients are provided here as CEL files and are available for further analysis. The data fill a major gap in knowledge regarding the systemic changes that underlie skin specific manifestations in cutaneous lupus. The data can be used to link differential gene expression to a broad range of biological processes and pathways underlying the mechanism of CCLE.

Data, materials and methods

The raw data files (CEL files) that were used in the analysis and interpretation in [3] are available in Supplementary information. Sample IDs are: LE1008B LE1009B LE1011B NL1004B NL1013B NL1014B. We used the Affymetrix Human Genome U95set GeneChip according to standard Affymetrix protocols to analyze gene expression from blood samples of CCLE patients (n=3) and healthy control individuals (n=3). We used Affymetrix expression console to check the quality of each individual CEL file. Gene expression data was imported into Partek Genomic Suite v 6.6 as CEL files using default parameters. Preprocessing: RMA, including log 2 transformation, quantile normalization, background correction and median polish probe set summarization to bring mean expression values of all 6 arrays to the same scale. We performed both unsupervised and supervised hierarchical cluster analysis and established differentially expressed genes (DEGs). Pathway and biological processes-based analyses were performed via enrichment analyses in DAVID and Metacore. Details of methodology used are provided in materials and methods and supplementary materials and methods [3].
Subject areaDermatology
Organism/cellHomo sapiens
More specific subject areaChronic cutaneous lupus erythematosus (CCLE) blood samples
How data was acquiredAffymetrix GeneChip HG-U95set
Data formatRaw data: CEL files
Experimental factorsCCLE patients and healthy control comparison
Experimental featuresWe performed both unsupervised and supervised analysis and established differentially expressed genes (DEGs) between CCLE patient and healthy control blood samples. The DEGs were then subjected to a pathway and biological processes-based enrichment analyses in DAVID and Metacore
Data source locationPatients diagnosed with CCLE and more specifically, DLE were recruited into the study from the Dermatology Outpatient Clinic of New York Presbyterian Hospital, Cornell University
Data accessibilityData is available with this article
  3 in total

1.  Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation.

Authors:  R Dey-Rao; A A Sinha
Journal:  Genomics       Date:  2014-11-18       Impact factor: 5.736

Review 2.  Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets.

Authors:  J Wenzel; S Zahn; T Tüting
Journal:  Lupus       Date:  2010-08       Impact factor: 2.911

3.  Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).

Authors:  Cyrus Biazar; Johanna Sigges; Nikolaos Patsinakidis; Vincent Ruland; Susanne Amler; Gisela Bonsmann; Annegret Kuhn
Journal:  Autoimmun Rev       Date:  2012-09-18       Impact factor: 9.754

  3 in total
  2 in total

1.  Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.

Authors:  Rama Dey-Rao; Animesh A Sinha
Journal:  BMC Genomics       Date:  2017-01-28       Impact factor: 3.969

2.  In silico Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target.

Authors:  Rama Dey-Rao; Animesh A Sinha
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.